Proteogenix : Quelles floorutions custom for the antibodies, peptides, genes and proteins ?

Proteogenix is a French specialist in custom antibodies, peptide synthesis, synthetic genes and recombinant proteins. Its integrated approach — from design to validation — helps laboratories in R&D, quality control and diagnostics accelerate their projects. With proven discovery platforms and rigorous project management, Proteogenix delivers highly specific reagents, ready for industrialisation. Dutscher distributes and orchestrates these services to provide tailored, reliable and fully documented outcomes.

A laboratory specialist born in the heart of Alsace

Founded in the heart of Alsace, near Strasbourg, Proteogenix was built on a simple belief: bring together molecular biology and immunology to deliver better-designed reagents, faster. Over the years, the company has expanded its offering from antibody development to gene synthesis, peptides and recombinant proteins, to cover the entire chain from design through to production. By investing in high-throughput selection processes and rigorous quality management, it now supports academic teams, biotechs, pharma and the diagnostics sector worldwide. Its responsive organisation and service mindset make it a long-term partner for sensitive, confidential projects.

Expertise and fields of specialisation

At the core of Proteogenix’s expertise: the discovery and engineering of antibodies. Depending on your need, the brand deploys hybridoma, phage display or single B-cell approaches, with application-driven screening campaigns (ELISA, flow cytometry, WB, IF). It offers humanisation, affinity maturation and reformatting into IgG, scFv or Fab, delivering reagents fit for research, assay development and technology transfer to manufacturing. The portfolio is completed by peptide synthesis (epitopes, libraries, conjugations) and synthetic genes, as well as expression of recombinant proteins in CHO/HEK, E. coli or insect cells, with purification and purity/endotoxin QC. Biophysical analyses (e.g. kinetics by BLI/SPR when required) and cross-validation on relevant matrices strengthen result robustness. Each lot ships with a traceability dossier and performance data; customer confidentiality and intellectual property are respected. Formats, buffers and quality grades are tuned to context (RUO, evaluations for IVD) to ensure compatibility and smooth transfer. With Dutscher, laboratories benefit from upfront technical scoping, milestone-based oversight and secure logistics for reproducible deliverables that are ready to use on receipt.

Proteogenix products distributed by Dutscher

Frequently asked questions about the Proteogenix brand

What types of projects does Proteogenix support?
Custom antibodies (mono/polyclonal, recombinant), peptides, genes and proteins. From design through validation to production, with comprehensive quality control data.

Where are the services performed and how are they managed?
Projects are coordinated from France, with qualified facilities and partners. A dedicated project manager, clear milestones, regular reports and approvals at every stage through to delivery.

What are the typical development timelines?
They vary by technology and application. Quoted in the proposal with a detailed schedule; accelerated options are available depending on complexity and antigen availability.

Who owns the intellectual property of the sequences?
Unless otherwise agreed, the sequences and reagents generated for your project belong to you. Proteogenix signs NDAs and guarantees the confidentiality of your samples and data.

What quality controls are provided on delivery?
Batch record: methods, results (ELISA, purity, endotoxins if required), full traceability of materials and certificates. Formats/buffers tailored to the intended use (RUO/IVD evaluation).

Are the antibodies compatible with my applications?
Clones are selected and tested for the intended use. Formats (IgG, scFv, Fab) and buffer conditions optimised for ELISA, WB, IF or flow cytometry, according to your requirements.